241 related articles for article (PubMed ID: 12417981)
1. Critical parameters in the cytotoxicity of photodynamic therapy using a pulsed laser.
Seguchi K; Kawauchi S; Morimoto Y; Arai T; Asanuma H; Hayakawa M; Kikuchi M
Lasers Med Sci; 2002; 17(4):265-71. PubMed ID: 12417981
[TBL] [Abstract][Full Text] [Related]
2. Differences between cytotoxicity in photodynamic therapy using a pulsed laser and a continuous wave laser: study of oxygen consumption and photobleaching.
Kawauchi S; Morimoto Y; Sato S; Arai T; Seguchi K; Asanuma H; Kikuchi M
Lasers Med Sci; 2004; 18(4):179-83. PubMed ID: 15042420
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
Henderson BW; Sitnik-Busch TM; Vaughan LA
Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
[TBL] [Abstract][Full Text] [Related]
5. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of photodynamic therapy using PAD-S31 and diode laser on human liver cancer cells.
Date M; Fukuchi K; Namiki Y; Okumura A; Morita S; Takahashi H; Ohura K
Liver Int; 2004 Apr; 24(2):142-8. PubMed ID: 15078479
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy for human oral squamous cell carcinoma and xenografts using a new photosensitizer, PAD-S31.
Date M; Sakata I; Fukuchi K; Ohura K; Azuma Y; Shinohara M; Matsuzaki K; Namiki Y; Takahashi H
Lasers Surg Med; 2003; 33(1):57-63. PubMed ID: 12866122
[TBL] [Abstract][Full Text] [Related]
9. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
10. Do pulsed lasers produce an effective photodynamic therapy response?
Strasswimmer J; Grande DJ
Lasers Surg Med; 2006 Jan; 38(1):22-5. PubMed ID: 16392149
[TBL] [Abstract][Full Text] [Related]
11. Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.
Busetti A; Soncin M; Jori G; Kenney ME; Rodgers MA
Photochem Photobiol; 1998 Sep; 68(3):377-81. PubMed ID: 9747592
[TBL] [Abstract][Full Text] [Related]
12. Light dosimetry for intraperitoneal photodynamic therapy in a murine xenograft model of human epithelial ovarian carcinoma.
Lilge L; Molpus K; Hasan T; Wilson BC
Photochem Photobiol; 1998 Sep; 68(3):281-8. PubMed ID: 9747583
[TBL] [Abstract][Full Text] [Related]
13. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin.
Takahashi H; Itoh Y; Nakajima S; Sakata I; Iizuka H
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):257-65. PubMed ID: 15379877
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence detection of a new photosensitizer, PAD-S31, in tumour tissues and its use as a photodynamic treatment for skin tumours in dogs and a cat: a preliminary report.
Tanabe S; Yamaguchi M; Iijima M; Nakajima S; Sakata I; Miyaki S; Takemura T; Furuoka H; Kobayashi Y; Matsui T; Uzuka Y; Sarashina T
Vet J; 2004 May; 167(3):286-93. PubMed ID: 15080878
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
[TBL] [Abstract][Full Text] [Related]
16. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.
Kruijt B; van der Ploeg-van den Heuvel A; de Bruijn HS; Sterenborg HJ; Amelink A; Robinson DJ
Lasers Surg Med; 2009 Nov; 41(9):653-64. PubMed ID: 19802884
[TBL] [Abstract][Full Text] [Related]
17. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
Alexiades-Armenakas M
J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
[TBL] [Abstract][Full Text] [Related]
18. Fluence rate as a modulator of PDT mechanisms.
Henderson BW; Busch TM; Snyder JW
Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
Babilas P; Kohl E; Maisch T; Bäcker H; Gross B; Branzan AL; Bäumler W; Landthaler M; Karrer S; Szeimies RM
Br J Dermatol; 2006 Apr; 154(4):712-8. PubMed ID: 16536815
[TBL] [Abstract][Full Text] [Related]
20. Spatial distribution of liposome encapsulated tin etiopurpurin dichloride (SnET2) in the canine prostate: implications for computer simulation of photodynamic therapy.
Aniola J; Selman SH; Lilge L; Keck R; Jankun J
Int J Mol Med; 2003 Mar; 11(3):287-91. PubMed ID: 12579328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
